382P Sequential RAS mutation status evaluation in circulating free DNA (cfDNA) in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) starting first-line (1L) treatment with panitumumab (P) and chemotherapy (CT). PERSEIDA (Idylla Cohort) study

Autor: Valladares, M., Safont Aguileria, M.J., González-Flores, E., García Alfonso, P., López Muñoz, A.M., Aranda Aguilar, E., Falco Ferrer, E., Rodriguez-Salas, N., Cirera, L., Llanos-Munoz, M., Aparicio, J., Pimentel, P., Castillo Trujillo, A.O., Salgado Fernandez, M., Salud Salvia, M.A., Vidal Tocino, R., Massuti Sureda, B., Garcia-Carbonero, R., Vicente Conesa, M.A.D.L.A., Lloansi Vila, A.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S711-S711
Databáze: ScienceDirect